Skip to main content
Dx & Vx Co., Ltd. logo

Dx & Vx Co., Ltd. — Investor Relations & Filings

Ticker · 180400 ISIN · KR7180400004 KO Manufacturing
Open in API
Filings indexed 474 across all filing types
Latest filing 2024-09-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 180400

About Dx & Vx Co., Ltd.

https://www.dxvx.com/

Dx & Vx Co., Ltd. is a bio-healthcare company specializing in diagnostics and vaccine development. Its diagnostics division offers molecular diagnostic solutions, genomics and bioinformatics services, and customized companion diagnostics (CDx), leveraging an AI-based genome analysis platform. The company's therapeutic pipeline is centered on an innovative mRNA vaccine platform designed for long-term storage at room temperature. Key development areas include vaccines for infectious diseases, immuno-therapeutic cancer vaccines, oral treatments for obesity, and therapies for eye conditions. Additionally, Dx & Vx provides contract development, manufacturing, and sales organization (CDMO/CSO) services and commercializes microbiome-based products and health supplements.

Recent filings

Filing Released Lang Actions
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the results of a paid-in capital increase (rights offering and general public offering). It details the subscription results, including the number of shares subscribed and the subscription rate. This falls under the category of share issuance and capital changes, specifically reporting the outcome of a capital-raising event.
2024-09-12 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the results of a rights offering (paid-in capital increase). It details the subscription results, including the number of shares subscribed, the subscription rate, and the handling of fractional/unsubscribed shares. This falls under the category of capital changes and share issuance announcements.
2024-09-09 Korean
[기재정정]유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (DXVX) regarding the results of a rights offering (paid-in capital increase). It details the subscription results, the number of shares issued, and the handling of unsubscribed shares. This falls under the category of share issuance and capital changes.
2024-09-09 Korean
유상증자최종발행가액확정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement regarding the final issuance price for a paid-in capital increase (rights offering). It details the number of shares, the final price per share, and the calculation methodology used to determine this price. This falls under the category of share issuance and capital changes, specifically related to the pricing of a capital increase.
2024-09-03 Korean
[기재정정]투자설명서
Investor Presentation Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Investment Prospectus' (투자설명서). It explicitly states that the corrections are made due to the submission of the semi-annual report (반기보고서) and provides a detailed table of contents regarding the specific sections of the prospectus that have been updated (e.g., business risks, financial status, research and development costs). This is a regulatory filing related to a securities offering, which falls under the category of Regulatory Filings (RNS) as it does not fit into the specific categories of Annual Reports (10-K) or Interim Reports (IR) themselves, but rather acts as an amendment to a prospectus.
2024-09-03 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Capital Increase Decision' (유상증자결정) for DXVX Co., Ltd. It details the amendment of a previous filing (정정신고) concerning the final issuance price and funding purposes for a rights offering. This type of document is a formal regulatory filing related to share issuance and capital structure changes, which falls under the 'Share Issue/Capital Change' category.
2024-09-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.